Israeli cybersecurity company Glow has closed a $180 million funding round and was valued at $1.2 billion, Meital Weisberg reports for Globes. Thus, the startup received unicorn status about a year after its founding.
During this time, Glow completed three funding rounds: a $20 million seed, a $60 million Series A, and a $100 million Series B. The latest round was led by Sequoia Capital, Cyberstarts, Greenoaks and Redpoint Ventures. Index Ventures, former basketball player Omri Caspi’s Swish fund, Lux Capital and Holly Ventures also participated.
The company intends to use the raised funds to expand sales and marketing, hire employees, and further research and development. Glow currently employs about 100 people, about 70 of them in Israel. The company has offices in Israel and the United States and plans to expand operations in both countries.
Glow was founded by former Meta VP of Engineering and Onavo co-founder Roi Tiger, former Snowflake Cyber Strategy Lead Omer Singer, and former Claroty VP of R&D Ofir Aryeh, a Talpiot and 8200 alumnus.
The startup is developing a platform for protecting employee computers and other devices. According to the company, the spread of generative artificial intelligence and autonomous AI agents has created new risks: unknown programs and tools are increasingly entering corporate systems through employee devices, and attackers are using AI to quickly find vulnerabilities.
The Glow platform uses AI agents that learn about an organization’s work environment, its security policies, and user behavior. The system determines which programs and AI tools are safe and which should be blocked or removed.
The company estimates the market size for protecting employee devices at approximately $40 billion and says it already works with dozens of large organizations, including Fortune 500 companies.
Diving Into the Demand: Buy Dihydrocodeine Tablets Online UK
The Rising Demand for Co-Codamol in the UK
Untitled – June 25, 2026 at 16.17.40
Note : Understanding the Demand for Diazepam Valium 10 mg Tablets
View As Owner
Understanding the Growth in Demand for Pregabalin 300 mg in the UK – HackMD
Penzu
Understanding the Demand for Tramadol 50 mg Tablets
Understanding the Growing Demand to Buy Co Codamol Tablets
Simply Sleeping Pills
Sleeping Pills UK | Bark Profile
764452
Simply Sleeping Pills
Doctor Supervised Medication Advice For UK Patients Today
Evernote
Safe Sleep Aid Guidance For Better Patient Decisions
116804872998371745
spadedust5's Profile | VIRGINIA
banjoswitch7, Autore presso http://www.annunciogratis.net
方法の極み
prisoncellar4, Author at Nerve Blocks
User beretquiet3 – Mindwellnessforum Q&A
User shadelook8 – Kitchenanswershub Q&A
holequiet2 » DataLife Engine 9.3 By A2raya Team
User prisondust2 – piglix.com